Irritable bowel syndrome (IBS) affects about 20% of the general population, mainly women. It is a chronic functional gastrointestinal disorder with significantly altered gut microbiota in patients compared to healthy individuals. IBS significantly affects the patient’s quality of life and thus needs a stringent management plan. However, recent advances in diagnostics and therapeutic interventions have made IBS management relatively easier.
To know more about this topic, join Dr. Satish Midha in our exclusive MasterSeries session on “Current Trends in Managing Irritable Bowel Syndrome” on 8 th February 2023, 3:00 PM IST onwards. Stay tuned for more!
